Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Prednisone"" wg kryterium: Temat


Tytuł :
Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease: A pilot study.
Autorzy :
Gálvez-Romero JL; From the, Departamento de investigación, Hospital Regional, ISSSTE, Puebla, México.
Palmeros-Rojas O; Área de Matemáticas, Departamento de Preparatoria Agrícola, Universidad Autónoma Chapingo, Texcoco, México.
Real-Ramírez FA; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Sánchez-Romero S; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Tome-Maxil R; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Ramírez-Sandoval MP; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Olivos-Rodríguez R; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Flores-Encarnación SE; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Cabrera-Estrada AA; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Ávila-Morales J; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Cortés-Sánchez V; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Sarmiento-Padilla G; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Tezmol-Ramírez SE; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Aparicio-Hernández D; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Urbina-Sánchez MI; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Gómez-Pluma MÁ; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Cisneros-Méndez S; Departamento de Medicina Interna, Hospital Regional, ISSSTE, Puebla, México.
Rodríguez-Rivas DI; Departamento de Radiología, Hospital Regional, ISSSTE, Puebla, México.
Reyes-Inurrigarro S; Departamento del Servicio de Urgencias y Terapia Intensiva, Hospital Regional, ISSSTE, Puebla, México.
Cortés-Díaz G; Departamento del Servicio de Urgencias y Terapia Intensiva, Hospital Regional, ISSSTE, Puebla, México.
Cruz-Delgado C; Departamento del Servicio de Urgencias y Terapia Intensiva, Hospital Regional, ISSSTE, Puebla, México.
Navarro-González J; Departamento del Servicio de Epidemiología, Hospital Regional, ISSSTE, Puebla, México.
Deveaux-Homs J; Director Médico, Hospital Regional, Hospital Regional ISSSTE, Puebla, México.
Pedraza-Sánchez S; Unidad de Bioquímica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), and Facultad de Ciencias, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, México.
Pokaż więcej
Źródło :
Journal of internal medicine [J Intern Med] 2021 Jun; Vol. 289 (6), pp. 906-920. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
COVID-19/*drug therapy
Cyclosporine/*therapeutic use
Glucocorticoids/*therapeutic use
Methylprednisolone/*therapeutic use
Prednisone/*therapeutic use
COVID-19/mortality ; COVID-19/pathology ; Cyclosporine/adverse effects ; Drug Therapy, Combination ; Female ; Glucocorticoids/administration & dosage ; Humans ; Lung/pathology ; Male ; Methylprednisolone/administration & dosage ; Middle Aged ; Pilot Projects ; Prednisone/administration & dosage ; Treatment Outcome
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis.
Autorzy :
McNally BB; Arizona College of Osteopathic Medicine, Midwestern University, 19555 N. 59th Ave, Glendale, AZ, 85308, USA.
Carey EJ; Division of Gastroenterology and Hepatology, Mayo Clinic in Arizona, 5777 E. Mayo Blvd, Phoenix, AZ, 85054, USA. .
Pokaż więcej
Źródło :
Digestive diseases and sciences [Dig Dis Sci] 2021 May; Vol. 66 (5), pp. 1715-1719. Date of Electronic Publication: 2020 May 20.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Azathioprine/*therapeutic use
Glucocorticoids/*therapeutic use
Hepatitis, Autoimmune/*drug therapy
Immunosuppressive Agents/*therapeutic use
Prednisone/*therapeutic use
Aged ; Aged, 80 and over ; Azathioprine/adverse effects ; Drug Therapy, Combination ; Female ; Glucocorticoids/adverse effects ; Hepatitis, Autoimmune/diagnosis ; Hepatitis, Autoimmune/immunology ; Humans ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Prednisone/adverse effects ; Remission Induction ; Retrospective Studies ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial.
Autorzy :
Obermann M; Center for Neurology, Asklepios Hospitals Schildautal, Seesen, Germany; Department of Neurology, University Hospital Essen, Germany. Electronic address: .
Nägel S; Department of Neurology, University Hospital Essen, Germany; Department of Neurology, Martin Luther University, Halle, Germany.
Ose C; Center for Clinical Trials Essen (ZKSE) and Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Germany.
Sonuc N; Center for Clinical Trials Essen (ZKSE) and Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Germany.
Scherag A; Center for Clinical Trials Essen (ZKSE) and Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Germany; Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital, Jena, Germany.
Storch P; Department of Neurology, Jena University Hospital, Jena, Germany.
Gaul C; Migraine and Headache Clinic, Königstein, Germany.
Böger A; Department of Pain Medicine, Vitos Pain Centre Kassel, Kassel, Germany.
Kraya T; Department of Neurology, Martin Luther University, Halle, Germany; Department of Neurology, St Georg Hospital, Leipzig, Germany.
Jansen JP; Pain Center, Berlin, Germany.
Straube A; Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.
Freilinger T; Department of Neurology, Hospital Passau, Passau, Germany; Centre of Neurology, Hertie-Institute for Clinical Brain Research, Eberhard-Karls-University, Tuebingen, Germany.
Kaube H; Neurology and Headache-Center, Munich, Germany.
Jürgens TP; Department of Neurology, University Medical Centre Rostock, Rostock, Germany.
Diener HC; Center for Clinical Trials Essen (ZKSE) and Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Germany.
Katsarava Z; Department of Neurology, University Hospital Essen, Germany; Department of Neurology, Evangelic Hospital Unna, Unna, Germany; EVEX Medical Corporation, Tbilisi, Georgia; IM Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.
Kleinschnitz C; Department of Neurology, University Hospital Essen, Germany.
Holle D; Department of Neurology, University Hospital Essen, Germany.
Pokaż więcej
Źródło :
The Lancet. Neurology [Lancet Neurol] 2021 Jan; Vol. 20 (1), pp. 29-37. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug-Related Side Effects and Adverse Reactions*
Outcome Assessment, Health Care*
Calcium Channel Blockers/*pharmacology
Cluster Headache/*prevention & control
Glucocorticoids/*pharmacology
Prednisone/*pharmacology
Verapamil/*pharmacology
Adult ; Calcium Channel Blockers/administration & dosage ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Glucocorticoids/administration & dosage ; Glucocorticoids/adverse effects ; Humans ; Male ; Middle Aged ; Prednisone/administration & dosage ; Prednisone/adverse effects ; Verapamil/administration & dosage
Czasopismo naukowe
Tytuł :
Gastrointestinal: Recurrence of pembrolizumab-induced severe gastritis after tapering steroid therapy.
Autorzy :
Okubo Y; Department of Gastroenterology, Kobe City Medical Center General Hospital, Kobe, Japan.
Hosotani K; Department of Gastroenterology, Kobe City Medical Center General Hospital, Kobe, Japan.
Taniguchi Y; Department of Gastroenterology, Kobe City Medical Center General Hospital, Kobe, Japan.
Hara S; Department of Clinical Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.
Inokuma T; Department of Gastroenterology, Kobe City Medical Center General Hospital, Kobe, Japan.
Pokaż więcej
Źródło :
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2021 Mar; Vol. 36 (3), pp. 586. Date of Electronic Publication: 2020 Sep 18.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Antibodies, Monoclonal, Humanized/*adverse effects
Gastritis/*diagnostic imaging
Gastritis/*etiology
Prednisone/*adverse effects
Aged ; Drug Tapering ; Gastric Mucosa/pathology ; Gastritis/pathology ; Humans ; Infusions, Intravenous ; Male ; Prednisone/administration & dosage ; Recurrence ; Severity of Illness Index ; Tomography, X-Ray Computed ; Withholding Treatment
Czasopismo naukowe
Tytuł :
Avacopan for the Treatment of ANCA-Associated Vasculitis.
Autorzy :
Jayne DRW; From Addenbrooke's Hospital, Cambridge, United Kingdom (D.R.W.J.); the University of Pennsylvania, Philadelphia (P.A.M.); and ChemoCentryx, Mountain View, CA (T.J.S., P.B.).
Merkel PA; From Addenbrooke's Hospital, Cambridge, United Kingdom (D.R.W.J.); the University of Pennsylvania, Philadelphia (P.A.M.); and ChemoCentryx, Mountain View, CA (T.J.S., P.B.).
Schall TJ; From Addenbrooke's Hospital, Cambridge, United Kingdom (D.R.W.J.); the University of Pennsylvania, Philadelphia (P.A.M.); and ChemoCentryx, Mountain View, CA (T.J.S., P.B.).
Bekker P; From Addenbrooke's Hospital, Cambridge, United Kingdom (D.R.W.J.); the University of Pennsylvania, Philadelphia (P.A.M.); and ChemoCentryx, Mountain View, CA (T.J.S., P.B.).
Pokaż więcej
Corporate Authors :
ADVOCATE Study Group
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Feb 18; Vol. 384 (7), pp. 599-609.
Typ publikacji :
Clinical Trial, Phase III; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Aniline Compounds/*therapeutic use
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/*drug therapy
Glucocorticoids/*administration & dosage
Nipecotic Acids/*therapeutic use
Prednisone/*administration & dosage
Receptor, Anaphylatoxin C5a/*antagonists & inhibitors
Administration, Oral ; Aniline Compounds/adverse effects ; Azathioprine/administration & dosage ; Cyclophosphamide/administration & dosage ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Glucocorticoids/adverse effects ; Humans ; Immunosuppressive Agents/administration & dosage ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Nipecotic Acids/adverse effects ; Prednisone/adverse effects ; Recurrence ; Remission Induction ; Rituximab/administration & dosage
Czasopismo naukowe
Tytuł :
Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective study.
Autorzy :
Wang H; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Zhao Y; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Zhang X; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Si X; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Song P; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Xiao Y; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Yang X; Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Song L; Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Shi J; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Zhao H; Department of Liver Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Zhang L; Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Pokaż więcej
Źródło :
Cancer medicine [Cancer Med] 2021 Jan; Vol. 10 (1), pp. 188-198. Date of Electronic Publication: 2020 Nov 19.
Typ publikacji :
Journal Article
MeSH Terms :
Glucocorticoids/*administration & dosage
Immune Checkpoint Inhibitors/*adverse effects
Lung/*drug effects
Pneumonia/*drug therapy
Prednisone/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Beijing ; Female ; Glucocorticoids/adverse effects ; Humans ; Immunocompromised Host ; Lung/diagnostic imaging ; Lung/pathology ; Male ; Middle Aged ; Opportunistic Infections/etiology ; Opportunistic Infections/mortality ; Pneumonia/chemically induced ; Pneumonia/diagnosis ; Pneumonia/mortality ; Prednisone/adverse effects ; Recurrence ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Severity of Illness Index ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis.
Autorzy :
Amjad W; Institute of Digestive Heath and Liver Diseases, Mercy Medical Center, Baltimore, MD, 21202, USA.
Alukal J; Institute of Digestive Heath and Liver Diseases, Mercy Medical Center, Baltimore, MD, 21202, USA.
Doycheva I; Institute of Digestive Heath and Liver Diseases, Mercy Medical Center, Baltimore, MD, 21202, USA.
Zhang T; Institute of Digestive Heath and Liver Diseases, Mercy Medical Center, Baltimore, MD, 21202, USA.
Maheshwari A; Institute of Digestive Heath and Liver Diseases, Mercy Medical Center, Baltimore, MD, 21202, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Yoo H; Institute of Digestive Heath and Liver Diseases, Mercy Medical Center, Baltimore, MD, 21202, USA.
Thuluvath PJ; Institute of Digestive Heath and Liver Diseases, Mercy Medical Center, Baltimore, MD, 21202, USA. .; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. .
Pokaż więcej
Źródło :
Digestive diseases and sciences [Dig Dis Sci] 2020 Dec; Vol. 65 (12), pp. 3726-3733. Date of Electronic Publication: 2020 Feb 18.
Typ publikacji :
Journal Article
MeSH Terms :
Acetylcysteine*/administration & dosage
Acetylcysteine*/adverse effects
Hepatitis, Alcoholic*/complications
Hepatitis, Alcoholic*/diagnosis
Hepatitis, Alcoholic*/drug therapy
Hepatitis, Alcoholic*/mortality
Liver Cirrhosis*/diagnosis
Liver Cirrhosis*/etiology
Prednisone*/administration & dosage
Prednisone*/adverse effects
Adult ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/adverse effects ; Drug Monitoring/methods ; Drug Therapy, Combination/methods ; Female ; Free Radical Scavengers/administration & dosage ; Free Radical Scavengers/adverse effects ; Humans ; Male ; Outcome and Process Assessment, Health Care ; Renal Insufficiency/diagnosis ; Renal Insufficiency/etiology ; Survival Analysis ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
Autorzy :
Guo Y; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Wu X; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Liu L; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Zhang H; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Yang L; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Chen W; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Pokaż więcej
Źródło :
Renal failure [Ren Fail] 2020 Nov; Vol. 42 (1), pp. 122-130.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Glomerulonephritis, Membranous/*complications
Glomerulonephritis, Membranous/*drug therapy
Leflunomide/*therapeutic use
Nephrotic Syndrome/*complications
Prednisone/*therapeutic use
Adult ; Autoantibodies/blood ; Biomarkers/blood ; Cyclophosphamide/therapeutic use ; Drug Therapy, Combination ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Leflunomide/adverse effects ; Male ; Middle Aged ; Prednisone/adverse effects ; Proteinuria/drug therapy ; Receptors, Phospholipase A2/immunology ; Remission Induction ; Serum Albumin
Czasopismo naukowe
Tytuł :
High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study.
Autorzy :
Ma J; Department of Hematology and Oncology, Beijing Children's Hospital, Capital Medical University, Nanlishi Road No. 56, Xicheng District, Beijing, 100045, People's Republic of China.; Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children's Health, Beijing, 100045, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, 100045, China.
Fu L; Department of Hematology and Oncology, Beijing Children's Hospital, Capital Medical University, Nanlishi Road No. 56, Xicheng District, Beijing, 100045, People's Republic of China.; Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children's Health, Beijing, 100045, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, 100045, China.
Chen Z; Department of Hematology and Oncology, Beijing Children's Hospital, Capital Medical University, Nanlishi Road No. 56, Xicheng District, Beijing, 100045, People's Republic of China.; Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children's Health, Beijing, 100045, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, 100045, China.
Gu H; Department of Hematology and Oncology, Beijing Children's Hospital, Capital Medical University, Nanlishi Road No. 56, Xicheng District, Beijing, 100045, People's Republic of China.; Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children's Health, Beijing, 100045, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, 100045, China.
Ma J; Department of Hematology and Oncology, Beijing Children's Hospital, Capital Medical University, Nanlishi Road No. 56, Xicheng District, Beijing, 100045, People's Republic of China.; Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children's Health, Beijing, 100045, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, 100045, China.
Wu R; Department of Hematology and Oncology, Beijing Children's Hospital, Capital Medical University, Nanlishi Road No. 56, Xicheng District, Beijing, 100045, People's Republic of China. .; Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children's Health, Beijing, 100045, China. .; Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, 100045, China. .
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2020 Dec; Vol. 112 (6), pp. 773-779. Date of Electronic Publication: 2020 Sep 03.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms :
Dexamethasone/*administration & dosage
Drug Substitution/*methods
Prednisone/*administration & dosage
Thrombocytopenia/*drug therapy
Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Prednisone/adverse effects ; Prospective Studies ; Safety ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis.
Autorzy :
Hungria V; Santa Casa Medical School, São Paulo, Brazil. .
Martínez-Baños DM; Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Mateos MV; Myeloma Unit, University Hospital of Salamanca/IBSAL, Salamanca, Spain.
Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Cavo M; Seràgnoli Institute of Hematology, School of Medicine, Bologna University, Bologna, Italy.
Heeg B; Ingress-Health, Rotterdam, Netherlands.
Garcia A; Ingress-Health, Rotterdam, Netherlands.
Lam A; Janssen Global Services, LLC, Raritan, NJ, USA.
Machnicki G; Janssen LATAM, Buenos Aires, Argentina.
He J; Janssen Global Services, LLC, Raritan, NJ, USA.
Fernandez M; Janssen Cilag Farmacéutica SA, Buenos Aires, Argentina.
Pokaż więcej
Źródło :
Advances in therapy [Adv Ther] 2020 Dec; Vol. 37 (12), pp. 4996-5009. Date of Electronic Publication: 2020 Oct 16.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Bortezomib/*therapeutic use
Melphalan/*therapeutic use
Multiple Myeloma/*drug therapy
Prednisone/*therapeutic use
Aged ; Female ; Humans ; Latin America ; Male ; Middle Aged ; Prednisone/analogs & derivatives ; Progression-Free Survival ; Propensity Score ; Retrospective Studies ; Standard of Care
Czasopismo naukowe
Tytuł :
Pneumocystis jirovecii pneumonia prophylaxis in a 42-year-old woman on immunosuppressive therapy.
Autorzy :
Halani S; Department of Medicine (Halani, Andany, Shah), University of Toronto; Division of Infectious Diseases (Andany), Sunnybrook Health Sciences Centre; Division of General Internal Medicine (Shah), Toronto Western Hospital, Toronto, Ont.
Andany N; Department of Medicine (Halani, Andany, Shah), University of Toronto; Division of Infectious Diseases (Andany), Sunnybrook Health Sciences Centre; Division of General Internal Medicine (Shah), Toronto Western Hospital, Toronto, Ont.
Shah R; Department of Medicine (Halani, Andany, Shah), University of Toronto; Division of Infectious Diseases (Andany), Sunnybrook Health Sciences Centre; Division of General Internal Medicine (Shah), Toronto Western Hospital, Toronto, Ont. .
Pokaż więcej
Źródło :
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2020 Oct 26; Vol. 192 (43), pp. E1306-E1308.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Immunocompromised Host*
Anti-Inflammatory Agents/*therapeutic use
Dermatomyositis/*drug therapy
Pneumonia, Pneumocystis/*prevention & control
Prednisone/*therapeutic use
Administration, Oral ; Adult ; Anti-Inflammatory Agents/administration & dosage ; Antifungal Agents/therapeutic use ; Drug Administration Schedule ; Female ; Humans ; Prednisone/administration & dosage
Czasopismo naukowe
Tytuł :
Effectiveness of Steroid Treatment for Sudden Sensorineural Hearing Loss: A Meta-analysis of Randomized Controlled Trials.
Autorzy :
Li J; Beijing University of Chinese Medicine Subsidiary Dongfang Hospital, Beijing, China.
Ding L; Beijing University of Chinese Medicine Subsidiary Dongfang Hospital, Beijing, China.
Pokaż więcej
Źródło :
The Annals of pharmacotherapy [Ann Pharmacother] 2020 Oct; Vol. 54 (10), pp. 949-957. Date of Electronic Publication: 2020 Mar 04.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Dexamethasone/*therapeutic use
Glucocorticoids/*therapeutic use
Hearing Loss, Sensorineural/*drug therapy
Hearing Loss, Sudden/*drug therapy
Methylprednisolone/*therapeutic use
Prednisone/*therapeutic use
Administration, Oral ; Dexamethasone/administration & dosage ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Female ; Glucocorticoids/administration & dosage ; Humans ; Injection, Intratympanic ; Male ; Methylprednisolone/administration & dosage ; Middle Aged ; Prednisone/administration & dosage ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Association of prednisone and antinuclear antibodies with pregnancy outcomes in women with unexplained recurrent pregnancy loss.
Autorzy :
Sun S; Department of Obstetrics and Gynecology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Li C; Department of Obstetrics and Gynecology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Kou X; Department of Obstetrics and Gynecology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Chen C; Department of Obstetrics and Gynecology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Guo F; Department of Obstetrics and Gynecology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zhao A; Department of Obstetrics and Gynecology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Pokaż więcej
Źródło :
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2021 Sep; Vol. 154 (3), pp. 492-499. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article
MeSH Terms :
Abortion, Habitual*/drug therapy
Pregnancy Outcome*
Antibodies, Antinuclear ; Aspirin ; Female ; Humans ; Infant, Newborn ; Prednisone ; Pregnancy
Czasopismo naukowe
Tytuł :
Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis.
Autorzy :
Painschab MS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA; Division of Hematology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA; University of North Carolina Project Malawi, Lilongwe, Malawi. Electronic address: .
Kohler R; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Kimani S; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA; University of North Carolina Project Malawi, Lilongwe, Malawi.
Mhango W; University of North Carolina Project Malawi, Lilongwe, Malawi.
Kaimila B; University of North Carolina Project Malawi, Lilongwe, Malawi.
Zuze T; University of North Carolina Project Malawi, Lilongwe, Malawi.
Mithi V; University of North Carolina Project Malawi, Lilongwe, Malawi.
Kasonkanji E; University of North Carolina Project Malawi, Lilongwe, Malawi.
Mumba N; University of North Carolina Project Malawi, Lilongwe, Malawi.
Nyasosela R; Kamuzu Central Hospital, Lilongwe, Malawi.
Wheeler S; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Gopal S; Center for Global Health, National Cancer Institute, Rockville, MD, USA.
Pokaż więcej
Źródło :
The Lancet. Global health [Lancet Glob Health] 2021 Sep; Vol. 9 (9), pp. e1305-e1313. Date of Electronic Publication: 2021 Jul 22.
Typ publikacji :
Comparative Study; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Lymphoma, Large B-Cell, Diffuse/*therapy
Antineoplastic Combined Chemotherapy Protocols/economics ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cost-Benefit Analysis ; Cyclophosphamide/economics ; Cyclophosphamide/therapeutic use ; Doxorubicin/economics ; Doxorubicin/therapeutic use ; Female ; Humans ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Malawi ; Male ; Prednisone/economics ; Prednisone/therapeutic use ; Rituximab/economics ; Rituximab/therapeutic use ; Treatment Outcome ; Vincristine/economics ; Vincristine/therapeutic use
SCR Protocol :
CHOP protocol
Czasopismo naukowe
Tytuł :
Prednisone combined with letrozole reduced risk of ovarian hyperstimulation syndrome (OHSS) in women undergoing long-term gonadotropin-releasing hormone analog treatment.
Autorzy :
Fang L; Reproductive Center, Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Ruan M; Reproductive Center, Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Yang S; Reproductive Center, Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Qu X; Reproductive Center, Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia.
Chen H; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia.
Zhao J; Reproductive Center, Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Cheng J; Reproductive Center, Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Pokaż więcej
Źródło :
Annals of palliative medicine [Ann Palliat Med] 2021 Aug; Vol. 10 (8), pp. 8837-8847.
Typ publikacji :
Journal Article
MeSH Terms :
Ovarian Hyperstimulation Syndrome*/prevention & control
Female ; Gonadotropin-Releasing Hormone ; Humans ; Letrozole/therapeutic use ; Ovulation Induction ; Prednisone/adverse effects ; Pregnancy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Treatment of Metastatic Castration-resistant Prostate Cancer Patients With Abiraterone Acetate and Prednisone and Corresponding Survival Prognostic Factors.
Autorzy :
Jimenez Romero ME; Department of Urology, Puerto Real University Hospital, Cadiz, Spain.
Gallego MC; Department of Urology, Puerto Real University Hospital, Cadiz, Spain.
Navarro Serrato JC; Department of Urology, Puerto Real University Hospital, Cadiz, Spain.
Sanchez Hurtado MA; Independent Researcher, Cáceres, Spain.
Santotoribio JD; Department of Laboratory Medicine, Puerto Real University Hospital, Cadiz, Spain.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Aug; Vol. 41 (8), pp. 3955-3968.
Typ publikacji :
Journal Article
MeSH Terms :
Abiraterone Acetate/*therapeutic use
Antineoplastic Agents/*therapeutic use
Prednisone/*therapeutic use
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Aged ; Aged, 80 and over ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Prognosis ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/pathology
Czasopismo naukowe
Tytuł :
Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease.
Autorzy :
Pérez-Lamas L; Department of Hematology, Ramón y Cajal University Hospital - IRYCIS, Madrid, Spain.
Moreno-Jiménez G; Department of Hematology, Ramón y Cajal University Hospital - IRYCIS, Madrid, Spain.
Tenorio-Núñez MC; Department of Hematology, Ramón y Cajal University Hospital - IRYCIS, Madrid, Spain.
Velázquez-Kennedy K; Department of Hematology, Ramón y Cajal University Hospital - IRYCIS, Madrid, Spain.
Jiménez-Chillón C; Department of Hematology, Ramón y Cajal University Hospital - IRYCIS, Madrid, Spain.
Astibia-Mahillo B; Department of Hematology, Ramón y Cajal University Hospital - IRYCIS, Madrid, Spain.
Núñez-Torrón C; Department of Hematology, Ramón y Cajal University Hospital - IRYCIS, Madrid, Spain.
García-Gutiérrez V; Department of Hematology, Ramón y Cajal University Hospital - IRYCIS, Madrid, Spain.
Jiménez-Martín A; Department of Hematology, Ramón y Cajal University Hospital - IRYCIS, Madrid, Spain.
Vallés-Carboneras A; Department of Hematology, Ramón y Cajal University Hospital - IRYCIS, Madrid, Spain.
López-Jiménez JF; Department of Hematology, Ramón y Cajal University Hospital - IRYCIS, Madrid, Spain.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2021 Aug 01; Vol. 96 (8), pp. E288-E291. Date of Electronic Publication: 2021 May 15.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
SARS-CoV-2*
Anemia, Hemolytic/*etiology
Anemia, Hemolytic, Autoimmune/*complications
Ankyrins/*immunology
COVID-19 Vaccines/*adverse effects
Cryoglobulins/*immunology
Erythrocyte Membrane/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Vaccination/*adverse effects
Anemia, Hemolytic, Autoimmune/drug therapy ; Anemia, Hemolytic, Autoimmune/immunology ; Antibodies, Viral/immunology ; Antibody Specificity ; Cross Reactions ; Cryoglobulins/biosynthesis ; Female ; Humans ; Immunocompromised Host ; Immunosuppressive Agents/adverse effects ; Immunosuppressive Agents/therapeutic use ; Middle Aged ; Molecular Mimicry ; Prednisone/adverse effects ; Prednisone/therapeutic use
Raport
Tytuł :
Comparison of CHOP with THP-COP for peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective analysis using data from the population-based Osaka Cancer Registry.
Autorzy :
Kida S; Department of Hematology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka-shi, Osaka, 5418567, Japan.
Fuji S; Department of Hematology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka-shi, Osaka, 5418567, Japan. .
Morishima T; Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Nakata K; Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Miyashiro I; Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Ishikawa J; Department of Hematology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka-shi, Osaka, 5418567, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2021 Aug; Vol. 114 (2), pp. 246-251. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Doxorubicin/*analogs & derivatives
Lymphoma, T-Cell, Peripheral/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Combined Modality Therapy/adverse effects ; Combined Modality Therapy/methods ; Cyclophosphamide/adverse effects ; Cyclophosphamide/therapeutic use ; Disease Management ; Doxorubicin/adverse effects ; Doxorubicin/therapeutic use ; Female ; Health Care Surveys ; Hospitalization ; Humans ; Japan/epidemiology ; Lymphoma, T-Cell, Peripheral/diagnosis ; Lymphoma, T-Cell, Peripheral/epidemiology ; Male ; Middle Aged ; Prednisolone/adverse effects ; Prednisolone/therapeutic use ; Prednisone/adverse effects ; Prednisone/therapeutic use ; Prognosis ; Registries ; Retrospective Studies ; Treatment Outcome ; Vincristine/adverse effects ; Vincristine/therapeutic use
SCR Protocol :
CHOP protocol; VEP-THP protocol
Czasopismo naukowe
Tytuł :
Topical Management of Peristomal Pyoderma Gangrenosum: A Report of 3 Case Studies.
Autorzy :
Toyoda T; Tomohiro Toyoda, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Shinji Mitsuyama, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Eri Nagao, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Fumihito Abe, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Masaaki Kimura, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Yurie Seido, RN, WOC Nurse, Department of Nursing Care, Toho University Sakura Medical Center, Sakura, Japan.; Tetsuya Higuchi, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.
Mitsuyama S; Tomohiro Toyoda, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Shinji Mitsuyama, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Eri Nagao, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Fumihito Abe, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Masaaki Kimura, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Yurie Seido, RN, WOC Nurse, Department of Nursing Care, Toho University Sakura Medical Center, Sakura, Japan.; Tetsuya Higuchi, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.
Nagao E; Tomohiro Toyoda, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Shinji Mitsuyama, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Eri Nagao, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Fumihito Abe, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Masaaki Kimura, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Yurie Seido, RN, WOC Nurse, Department of Nursing Care, Toho University Sakura Medical Center, Sakura, Japan.; Tetsuya Higuchi, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.
Abe F; Tomohiro Toyoda, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Shinji Mitsuyama, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Eri Nagao, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Fumihito Abe, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Masaaki Kimura, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Yurie Seido, RN, WOC Nurse, Department of Nursing Care, Toho University Sakura Medical Center, Sakura, Japan.; Tetsuya Higuchi, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.
Kimura M; Tomohiro Toyoda, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Shinji Mitsuyama, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Eri Nagao, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Fumihito Abe, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Masaaki Kimura, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Yurie Seido, RN, WOC Nurse, Department of Nursing Care, Toho University Sakura Medical Center, Sakura, Japan.; Tetsuya Higuchi, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.
Seido Y; Tomohiro Toyoda, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Shinji Mitsuyama, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Eri Nagao, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Fumihito Abe, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Masaaki Kimura, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Yurie Seido, RN, WOC Nurse, Department of Nursing Care, Toho University Sakura Medical Center, Sakura, Japan.; Tetsuya Higuchi, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.
Higuchi T; Tomohiro Toyoda, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Shinji Mitsuyama, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Eri Nagao, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Fumihito Abe, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Masaaki Kimura, MD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.; Yurie Seido, RN, WOC Nurse, Department of Nursing Care, Toho University Sakura Medical Center, Sakura, Japan.; Tetsuya Higuchi, MD, PhD, Department of Dermatology, Toho University Sakura Medical Center, Sakura, Japan.
Pokaż więcej
Źródło :
Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society [J Wound Ostomy Continence Nurs] 2021 Jul-Aug 01; Vol. 48 (4), pp. 345-349.
Typ publikacji :
Journal Article
MeSH Terms :
Adalimumab/*therapeutic use
Anti-Inflammatory Agents/*therapeutic use
Glucocorticoids/*therapeutic use
Inflammatory Bowel Diseases/*complications
Ostomy/*adverse effects
Pyoderma Gangrenosum/*drug therapy
Steroids/*therapeutic use
Surgical Stomas/*adverse effects
Adalimumab/administration & dosage ; Administration, Topical ; Adult ; Aged, 80 and over ; Anti-Inflammatory Agents/administration & dosage ; Crohn Disease/diagnosis ; Crohn Disease/therapy ; Female ; Glucocorticoids/administration & dosage ; Humans ; Postoperative Complications ; Prednisone/administration & dosage ; Prednisone/therapeutic use ; Pyoderma Gangrenosum/diagnosis ; Steroids/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
Autorzy :
Lebedev L; Departments of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel.
Sapojnikov M; Departments of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel.
Wechsler A; Departments of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel.
Varadi-Levi R; Departments of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel.
Zamir D; Department of Medicine D, Barzilai University Medical Center, Ashkelon, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel.
Tobar A; Department of Pathology, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
Levin-Iaina N; Departments of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel.
Fytlovich S; Department of Medical Laboratories, Barzilai University Medical Center, Ashkelon, Israel.
Yagil Y; Departments of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel. Electronic address: .
Pokaż więcej
Źródło :
American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2021 Jul; Vol. 78 (1), pp. 142-145. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Case Reports
MeSH Terms :
Acute Kidney Injury*/etiology
Acute Kidney Injury*/pathology
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/adverse effects
Nephrosis, Lipoid*/diagnosis
Nephrosis, Lipoid*/drug therapy
Nephrosis, Lipoid*/etiology
Nephrosis, Lipoid*/physiopathology
Nephrotic Syndrome*/diagnosis
Nephrotic Syndrome*/etiology
COVID-19/*prevention & control
Prednisone/*administration & dosage
Biopsy/methods ; COVID-19/epidemiology ; Creatinine/blood ; Edema/diagnosis ; Edema/etiology ; Glucocorticoids/administration & dosage ; Humans ; Male ; Middle Aged ; Renal Elimination/drug effects ; SARS-CoV-2 ; Treatment Outcome ; Urinalysis/methods
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies